Platelet to Lymphocyte Ratio in Polymyositis as a Marker of Disease Activity

Clinical Laboratory
|June 29, 2016
PubMed
Abstract

Insights

The platelet to lymphocyte ratio (PLR) is elevated in polymyositis (PM) patients and correlates with disease activity. This suggests PLR can help assess systemic inflammation and disease severity in PM.

Area of Science:

  • Rheumatology
  • Immunology
  • Biomarkers

Background:

  • Systemic inflammation is a key feature in autoimmune diseases.
  • Polymyositis (PM) is a rare inflammatory myopathy.
  • The platelet to lymphocyte ratio (PLR) is an emerging marker for systemic inflammation.

Purpose of the Study:

  • To investigate the association between PLR and polymyositis (PM).
  • To explore the utility of PLR in assessing disease activity in PM patients.

Main Methods:

  • A case-control study involving 46 newly diagnosed PM patients and 128 healthy controls.
  • Muscle weakness assessed using the Manual Muscle Test (MMT).
  • Statistical analysis including correlation and logistic regression.

Main Results:

  • PM patients exhibited significantly higher PLR and Neutrophil to Lymphocyte Ratio (NLR) compared to controls.
  • PLR positively correlated with NLR, ESR, and platelet count, and negatively with lymphocyte count.
  • A significant inverse correlation was found between PLR and MMT scores, indicating higher PLR with greater muscle weakness.

Conclusions:

  • PLR is significantly associated with polymyositis (PM).
  • PLR may serve as a valuable biomarker for estimating disease activity in PM patients.

Related Concept Videos